Cargando…

TXNRD1 Is an Unfavorable Prognostic Factor for Patients with Hepatocellular Carcinoma

Thioredoxin reductase 1 (TXNRD1) which is a selenocysteine-containing protein is overexpressed in many malignancies. Its role in the hepatocellular carcinoma (HCC) prognosis has not been investigated. In this study, we investigated whether TXNRD1 functions as an independent prognostic factor for HCC...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fu, Binsheng, Meng, Wei, Zeng, Xiancheng, Zhao, Hui, Liu, Wei, Zhang, Tong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2017
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5425838/ https://www.ncbi.nlm.nih.gov/pubmed/28536696 http://dx.doi.org/10.1155/2017/4698167

Ejemplares similares

DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma
por: Wu, Hao, et al.
Publicado: (2021)

USF2-mediated upregulation of TXNRD1 contributes to hepatocellular carcinoma progression by activating Akt/mTOR signaling
por: Huang, Wen-ya, et al.
Publicado: (2022)

GRAM domain-containing protein 1A (GRAMD1A) promotes the expansion of hepatocellular carcinoma stem cell and hepatocellular carcinoma growth through STAT5
por: Fu, Binsheng, et al.
Publicado: (2016)

Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma
por: Bai, Hansong, et al.
Publicado: (2019)

miR-125b-5p inhibits cell proliferation, migration, and invasion in hepatocellular carcinoma via targeting TXNRD1
por: Hua, Shengni, et al.
Publicado: (2019)

LRG1 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
por: Wang, Chun-Hua, et al.
Publicado: (2015)

SYNPO2 upregulation is an unfavorable prognostic factor for nasopharyngeal carcinoma patients
por: Chang, Shih-Lun, et al.
Publicado: (2023)

TXNRD1: A Key Regulator Involved in the Ferroptosis of CML Cells Induced by Cysteine Depletion In Vitro
por: Liu, Shuhan, et al.
Publicado: (2021)

Cytoprotective Nrf2 Pathway Is Induced In Chronically Txnrd 1-Deficient Hepatocytes
por: Suvorova, Elena S., et al.
Publicado: (2009)

Genetic Variations in TXNRD1 as Potential Predictors of Drug-Induced Liver Injury
por: Kwon, Jae-Woo, et al.
Publicado: (2012)

MAP Kinase-Interacting Kinase 1 Promotes Proliferation and Invasion of Hepatocellular Carcinoma and Is an Unfavorable Prognostic Biomarker
por: Wang, Xujing, et al.
Publicado: (2018)

PRAF2 expression indicates unfavorable clinical outcome in hepatocellular carcinoma
por: Wang, Chun-Hua, et al.
Publicado: (2018)

Alcohol drinking as an unfavorable prognostic factor for male patients with nasopharyngeal carcinoma
por: Chen, Yu-Pei, et al.
Publicado: (2016)

Decreased serum exosomal miR-320a expression is an unfavorable prognostic factor in patients with hepatocellular carcinoma
por: Hao, Xinjie, et al.
Publicado: (2020)

Downregulation of miR-33a-5p in Hepatocellular Carcinoma: A Possible Mechanism for Chemotherapy Resistance
por: Meng, Wei, et al.
Publicado: (2017)

KLK6 Functions as an Oncogene and Unfavorable Prognostic Factor in Bladder Urothelial Carcinoma
por: Zhao, Kaidong, et al.
Publicado: (2022)

Significant down-regulation of growth hormone receptor expression revealed as a new unfavorable prognostic factor in hepatitis C virus-related hepatocellular carcinoma
por: Lin, Ching-Chih, et al.
Publicado: (2021)

Co-expression of KIAA1199 and hypoxia-inducible factor 1α is a biomarker for an unfavorable prognosis in hepatocellular carcinoma
por: Wang, Dan, et al.
Publicado: (2020)

Identification of genes predicting unfavorable prognosis in hepatitis B virus-associated hepatocellular carcinoma
por: Sha, Meng, et al.
Publicado: (2021)

Inhibition of TXNRD or SOD1 overcomes NRF2-mediated resistance to β-lapachone
por: Torrente, Laura, et al.
Publicado: (2020)

High expression of MAGE-A9 correlates with unfavorable survival in hepatocellular carcinoma
por: Gu, Xuefeng, et al.
Publicado: (2014)

High expression of GFAT1 predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Li, Lili, et al.
Publicado: (2017)

Tescalcin is an unfavorable prognosis factor that regulats cell proliferation and survival in hepatocellular carcinoma patients
por: Zhou, Zhong‐Guo, et al.
Publicado: (2020)

Circ0120816 acts as an oncogene of esophageal squamous cell carcinoma by inhibiting miR-1305 and releasing TXNRD1
por: Li, Xiaoyong, et al.
Publicado: (2020)

Identification of GRB2 and GAB1 Coexpression as an Unfavorable Prognostic Factor for Hepatocellular Carcinoma by a Combination of Expression Profile and Network Analysis
por: Zhang, Yanqiong, et al.
Publicado: (2013)

Correlation between TXNRD1/HO-1 expression and response to neoadjuvant chemoradiation therapy in patients with esophageal squamous cell carcinoma
por: Akaishi, Ryujiro, et al.
Publicado: (2022)

miR-875-5p regulates IR and inflammation via targeting TXNRD1 in gestational diabetes rats
por: Fu, Songbo, et al.
Publicado: (2021)

WTAP Is Correlated With Unfavorable Prognosis, Tumor Cell Proliferation, and Immune Infiltration in Hepatocellular Carcinoma
por: Liang, Linjun, et al.
Publicado: (2022)

Overexpression of WWP1 Promotes tumorigenesis and predicts unfavorable prognosis in patients with hepatocellular carcinoma
por: Zhang, Xiao-Fei, et al.
Publicado: (2015)

Selenoprotein TXNRD3 supports male fertility via the redox regulation of spermatogenesis
por: Dou, Qianhui, et al.
Publicado: (2022)

TINCR expression is associated with unfavorable prognosis in patients with hepatocellular carcinoma
por: Tian, Feng, et al.
Publicado: (2017)

Downregulation of GNA14 in hepatocellular carcinoma indicates an unfavorable prognosis
por: Yu, Tao, et al.
Publicado: (2020)

High Expression of PIGC Predicts Unfavorable Survival in Hepatocellular Carcinoma
por: Guo, Xufeng, et al.
Publicado: (2021)

Quantitative proteomics identification of phosphoglycerate mutase 1 as a novel therapeutic target in hepatocellular carcinoma
por: Ren, Fenglian, et al.
Publicado: (2010)

Protein kinase CK2α catalytic subunit is overexpressed and serves as an unfavorable prognostic marker in primary hepatocellular carcinoma
por: Zhang, Hong-Xia, et al.
Publicado: (2015)

Overexpression of the recently identified oncogene REDD1 correlates with tumor progression and is an independent unfavorable prognostic factor for ovarian carcinoma
por: Chang, Bin, et al.
Publicado: (2018)

Evaluation of prognostic factors and the role of chemotherapy in unfavorable carcinoma of unknown primary site: a 10-year cohort study
por: Chen, Kuo-Wei, et al.
Publicado: (2012)

Corrigendum to Long Noncoding RNA PTTG3P Expression Is an Unfavorable Prognostic Marker for Patients With Hepatocellular Carcinoma
Publicado: (2020)

MicroRNA-124 regulates the radiosensitivity of non-small cell lung cancer cells by targeting TXNRD1
por: Hao, Chuncheng, et al.
Publicado: (2017)

The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1
por: Cheff, Dorian M., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4e2rgi8rig26l934e4g9afgslv